Clinical evaluation of near-continuous oral micronized progesterone therapy in estrogenized postmenopausal women

Gynecological Endocrinology

Volumn 10, Issue 1, 1996, Pages 41-47

  Bolaji, I I ^a,c   Mortimer, G ^a   Grimes, H ^a   Tallon, D F ^a   O'Dwyer, E ^a   Fottrell, P F ^b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

Author keywords

Estrogen; Micronized progesterone; Postmenopausal women

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROGESTERONE; TRIACYLGLYCEROL;

ADULT; AGED; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; ENDOMETRIUM ATROPHY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VAGINA BLEEDING;

EID: 0029968773     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609041269     Document Type: Article

References (17)

1. Smith, D. C., Prentice, R., Thompson, D. J. and Herrmann, W. L. (1975). Association of exogenous oestrogen and endometrial carcinoma. N. Engl. J. Med., 293, 1164-7
2. Ziel, H. K. and Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated oestrogens. N. Engl. J. Med., 293, 1167-70
3. Gambrell, R. D. Jr, Massey, F. M., Castaneda, T. A., Ugenas, A. J., Ricci, C. A. and Wright, J. M. (1980). Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet. Gynecol., 55, 732-8
4. Gambrell, R. D. Jr, Bagnell, C. A. and Greenblatt, R. B. (1983). Role of oestrogens and progesterone in the aetiology and prevention of endometrial cancer: review. Am. J. Obstet. Gynecol., 146, 696-707
5. Whitehead, M. I., Siddle, N. C., Townsend, P. T., Lane, G. and King, R. J. B. (1983). The use of progestins and progesterone in the treatment of climacteric and postmenopausal symptoms. In Bardin, C. W., Milgrom, E. and Mauvais-Jarvis, P. (eds.) Progesterone and Progestins, pp. 277-94. (New York: Raven Press)
6. Lind, T., Cameron, E. C., Hunter, W. M., Leon, C., Moran, P. F., Oxley, A., Gerrard, J. and Lind, U. C. (1979). A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br. J. Obstet. Gynaecol., 86 (Suppl. 3), 1-29
7. Magos, A. L., Brincat, M., Studd, J. W. W., Wardle, P., Schlesinger, P. and O'Dowd, T. (1985). Amenorrhoea and endometrial atrophy with continuous oral oestrogen and progestogen therapy in postmenopausal women. Obstet. Gynecol., 65, 496-9
8. Magos, A. L., Brewster, E., Singh, R., O'Dowd, T., Brincat, M. and Studd, J. W. W. (1986). The effects of norethisterone in postmenopausal women on hormone replacement therapy: a model for the premenstrual syndrome. Br.J. Obstet. Gynaecol., 93, 1290-6
9. Whitehead, M. I., Townsend, P. T., Gill, D. K., Collms, W. P. and Campbell, S. (1980). Absorp-tion and metabolism of oral progesterone. Br. Med. J., 280, 825-7
10. Maxson, W. S. and Hargrove, J. T. (1985). Bioavailability of oral micronised progesterone. Fertil. Steril., 44, 622-6
11. Bolaji, I. I., Tallon, D., O'Dwyer, E. M. and Fottrell, P. F. (1993). Assessment of bioavailability of micronised oral progesterone using a salivary progesterone enzymeimmunoassay. Gynecol. Endocrinol., 7, 101-10
12. Helsinki Declaration (1989). Helsinki Declaration adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964, and as revised by the 41st World Medical Assembly, Hong Kong, May
13. Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502
14. Hargrove, J. T., Maxson, W. S. and Wentz, A. C. (1989). Absorption of oral progesterone is influenced by vehicle and particle size. Am. J. Obstet. Gynecol., 161, 948-51
15. Whitehead, M. I., Hillard, T. C. and Crook, D. (1990). The role and use of progestogens. Obstet. Gynecol., 75, 59S-76S
16. Bolaji, I. I. and O'Dwyer, E. M. (1992). Postmenopausal cyclic eruptions: autoimmune progesterone dermatitis. Eur. J. Obstet. Gynecol. Reprod. Biol., 47, 169-71
17. Punnonen, R., Liukko, P., Cortes-Preito, J., Eydam, F., Milojevic, S., Trevoux, R., Chryssikopoulos, E., Franchi, F., Luisi, M. and Kicovic, P. M. (1984). Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in postmenopausal and oophorectomised women. Maturitas, 5, 281-6